In pediatric oncology, clinical trials are conducted to improve survival rates, understand disease biology, and prevent and/or improve management of treatment-related acute and long-term side effects. The majority of children newly diagnosed with cancer in North America are treated on Children’s Oncology Group (COG) clinical trials. In the last 50 years, clinical trials in pediatric oncology have increased the overall 5-year survival rate from under 10% to over 80% today.
Nurses are an integral part of the success of these trials. Understanding the complexity of these trials is vital to the care of patients with cancer and their families. This session will provide a brief overview of the Children’s Oncology Group and the history of clinical trials, review COG protocol navigation, and present key components of delivering care to patients enrolled on clinical trials. Phases of trials, regulatory requirements, informed consent, and principles of Good Clinical Practice, including nursing documentation, will be discussed. Practical implications for nurses caring for patients on clinical trials will be presented, and exemplars of nursing and family experiences will be shared. This session will help prepare the nurse to manage the increasing clinical trial complexity and deliver excellent cancer care to patients and families enrolled on clinical trials.
- Closing Keynote: Why We Chose Nursing and How Nursing Continues to Choose Us (104)
- General Session: Nursing Emotional IQ (103)
- General Session: Controversies and Conundrums in the Use of Opioids in AYAs with Cancer (102)
- Opening Keynote: The American Nurse: Stories of Life-Changing Impact (101)
- Paper Presentation: Education Across the Cancer Care Continuum — Evidence-Based Interprofessional Palliative Care Education: Lessons for Pediatric Oncology Clinicians (204-2)